X0508 4 2023-12-15 0 0001796280 Oric Pharmaceuticals, Inc. ORIC 0001586894 Multani Pratik S C/O ORIC PHARMACEUTICALS, INC. 240 E. GRAND AVE., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-12-15 4 M 0 14042 0.00 A 29091 D Common Stock 2023-12-15 4 S 0 5282 8.5859 D 23809 D Restricted Stock Unit 2023-12-15 4 M 0 6042 0.00 D Common Stock 6042 6042 D Restricted Stock Unit 2023-12-15 4 M 0 8000 0.00 D Common Stock 8000 16000 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the "Issuer") Common Stock. Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan. Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. Represents the weighted average share price of an aggregate total of 5,282 shares sold in the price range of $8.57 to $8.795 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024. 1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025. /s/ Christian Kuhlen, attorney-in-fact 2023-12-19